Trials / Terminated
TerminatedNCT05394402
A Trial of SHR0410 Injection in Postsurgical Pain Management
A Phase Ⅱ, Randomized, Double-blind, Placebo-controlled ， Evaluation of the Safety, Efficacy of SHR0410 Injection for Pain Management Following Orthopaedic Surgery
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy, safety of SHR0410 Injection and to explore the reasonable of SHR0410 Injection for Pain Management after Orthopaedic Surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0410 Injection | SHR0410 Injection |
| DRUG | Placebo for SHR0410 Injection | SHR0410 Injection blank preparation |
Timeline
- Start date
- 2022-08-09
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2022-05-27
- Last updated
- 2025-06-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05394402. Inclusion in this directory is not an endorsement.